Figure 3From: A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transitionMesenchymal marker expression. A) αSMA, B) VIM and C) FN gene expression in HK2 cells treated with or without FGF-2 and sulodexide. The results represent the mean ± SD of two independent experiments performed in triplicate.Back to article page